About Editas Medicine (EDIT)
Editas Medicine, Inc. is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting their disease-causing genes. It operates through developing and commercializing genome editing technology segment. I... Read more
- USD2.79
- USD3.02
- USD2.70
- USD5.91
- 39.60%
- 36M
- 2.96M
- 241M
- 0.91
- -51.00%
Stock News
7 hours ago
Antero Resources: Natural Gas Prices Remain Rangebound, Maintain Buy
SeekingAlpha
yesterday
Fed’s Williams says tariffs are pushing up inflation, and he expects even higher prices in coming months
MarketWatch
yesterday
Jim Cramer says firing Fed Chair Powell can only hurt Trump
CNBC
yesterday
What happens if Trump fires Fed Chair Powell: 'This would be a mess,' analysts warn
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
